1. Introduction {#sec0001}
===============

Alzheimer\'s disease (AD) is neuropathologically characterized by extracellular amyloid plaques (Aβ) and intracellular tau neurofibrillary tangles ([@bib0001]; [@bib0002]). The advent of the positron emission tomography (PET) tracer \[^18^F\]flortaucipir(\[^18^F\]AV-1451) has made it possible to image tau pathology in vivo ([@bib0003]). \[^18^F\]Flortaucipir binds with high affinity to paired helical filaments (PHF) of tau, with strong correlations to the clinical diagnosis of AD and degree of cognitive impairment ([@bib0004]; [@bib0005]; [@bib0006]; [@bib0007]; [@bib0008]). However, the tracer is also characterized by off-target binding in the basal ganglia, thalamus and choroid plexus ([@bib0003]; [@bib0009]; [@bib0010]). Off-target binding in the choroid plexus may cause spill-in to the anatomical nearby hippocampus. This spill-in effect may artificially increase hippocampal \[^18^F\]flortaucipir signal leading to an inaccurate quantification of hippocampal tau load. Indeed, choroid plexus spill-in may partly explain the strong associations between the choroid plexus and hippocampus ([@bib0006]; [@bib0011]; [@bib0012]; [@bib0013]). This is potentially problematic as the hippocampus is among the earliest regions affected by tau pathology and accurate assessment of this early tau accumulation is of utmost importance in our understanding of the natural time course of AD ([@bib0014]).

Former studies investigating specifically the role of hippocampal tau in relation to the clinical diagnosis of AD have generated inconsistent results. Some studies, using semi-quantitative techniques, accurately distinguished AD patients from cognitive normal participants with hippocampal \[^18^F\]flortaucipir uptake ([@bib0012]), while others did not ([@bib0005]; [@bib0007]). Eroding voxels of the hippocampus ([@bib0013]), various partial volume correction (PVC) methods ([@bib0006]; [@bib0013]; [@bib0015]) and linear regression approaches ([@bib0011]; [@bib0015]) have been proposed to reduce the spill-in effect of the choroid plexus\[13\]. These methods resulted in a decreased association between hippocampal and choroid plexus tracer uptake, presumably due to lowering the spill-in effects ([@bib0006]; [@bib0011]; [@bib0012]; [@bib0013]). However, limited evidence is available regarding the effects of an optimized hippocampal \[^18^F\]flortaucipir signal on the relationships between tau pathology and cognition ([@bib0011]).

Here we build upon previous work ([@bib0013]) in which we used a PVC method that combines Van Cittert iterative deconvolution with highly constrained back projection (HDH). This PET-only based PVC method results in a better quantification of the dynamic PET signal ([@bib0016]). The use of PVC HDH with an manually eroded hippocampal volume-of-interest (VOI) effectively reduced the spill in from the choroid plexus and improved the quantitative accuracy of the hippocampal tau load ([@bib0013]). However, this technique is time consuming and impractical due to the manually eroding of the hippocampus. In addition, the technique has not yet been validated using clinical parameters of AD, such as cognitive measures. This additional step is important because using PVC could potentially increase noise ([@bib0016]) and could blur the associations with clinical correlates of AD. Clinical validation of the HDH PVC method is therefore important, especially in AD where atrophy plays an important role and thus partial volume effects are to be expected.

As such, the purpose of the present study was to compare three different semi-automatic hippocampal VOIs and examine which hippocampal VOI showed the best correlation with cognitive performance. We hypothesised that the improved quantification of hippocampal tau load, using both PVC and an eroded hippocampus volumes (i.e. reducing spill-in effects), would provide higher accuracy for distinguishing AD from controls and would be most strongly related to cognition in a memory clinic population.

2. Methods {#sec0002}
==========

2.1. Participants {#sec0003}
-----------------

We included 109 subjects, 45 cognitively normal individuals with subjective cognitive decline (SCD) from the SCIENCe project ([@bib0017]) and 64 patients with cognitive impairment from the Amsterdam Dementia Cohort ([@bib0018], [@bib0019]). Among the 64 patients with cognitive impairment, nine patients were diagnosed with mild cognitive impairment (MCI) due to Alzheimer\'s disease(AD) ([@bib0020]) and 55 with AD dementia ([@bib0021]). All subjects visited the Alzheimer Center Amsterdam, Amsterdam UMC, location VUmc, for an extensive dementia screening. The standardized work up consists of a clinical evaluation by a neurologist, including physical examination, neuropsychological investigation, brain magnetic resonance imaging (MRI) and a lumbar puncture. A clinical diagnosis was established by a multidisciplinary consensus meeting ([@bib0018], [@bib0019]) and all AD/MCI patients had evidence for amyloid pathology determined by either an abnormal amyloid PET scan (*n* = 24) by visual read ([@bib0022]; [@bib0023]) and/or an AD-like CSF profile (*n* = 59) ([@bib0024]), or both CSF and PET(*n* = 20). Cognitively normal individuals with evidence of substantial Aβ pathology after visual reading of \[^18^F\]florbetapir Aß-PET scans SUVr~50-~70 min ([@bib0025]), were classified as amyloid positive subjects. In all cases with both CSF and PET data available, biomarkers were concordant. The study protocol was approved by the Medical Ethics Review Committee of the Amsterdam UMC VU Medical center. All patients provided written informed consent.

2.2. Image acquisition {#sec0004}
----------------------

Dynamic 130 min \[^18^F\]flortaucipir PET scan were acquired on a Philips Ingenuity TF-64 PET/CT scanner. The scanning protocol consisted of two dynamic PET scans of 60 and 50 min respectively, with a 20 min break in between ([@bib0013]; [@bib0026]). The first 60 min dynamic scan started simultaneously with a bolus injection 237 ± 13 MBq (injected mass 1.14±0.84 µg) of \[^18^F\]flortaucipir. The second PET scan was co-registered to the first dynamic PET scan using Vinci software ([@bib0027]). PET list mode data were rebinned into a total of 29 frames (1 × 15, 3 × 5, 3 × 10, 4 × 60, 2 × 150, 2 × 300, 4 × 600 and 10×300 s) and reconstructed using 3D RAMLA with a matrix size of 128 × 128 × 90 and a final voxel size of 2 × 2 × 2 mm^3^, including standard corrections for dead time, decay, attenuation, randoms and scatter.

All subjects also underwent a 3D-T1 weighted sequence on a 3.0 Tesla MRI scanner (Ingenuity TF PET/MR, Philips Medical Systems, Best, The Netherlands), and these images were co-registered to the averaged images (frame 8 -- 29) of the PET scan. The time lag between MR and PET scan was maximal 6 months (1.4 ± 2.2 months) for MCI/AD patients and 12 months (−3.0 ± 6.8 months) for cognitively normal individuals. The hippocampal volume of interest (VOI, Hammers template ([@bib0028])) was subsequently defined on the MR images and superimposed on the PET scan using PVElab ([@bib0029]). Hippocampal binding potential (BP~ND~) was generated using a basis function approach of the simplified reference method, i.e. receptor parametric mapping (RPM) with whole cerebellar gray matter as a reference region ([@bib0026], [@bib0030]; [@bib0001]).In addition, using the Hammers template ([@bib0028]), we constructed a ROI consisting of all cortical structures to obtain a measurement of global \[^18^F\]flortaucipir uptake. In our previous paper ([@bib0013]) we showed that quantification of hippocampal tau load can be improved with the combination of PVC HDH and manually eroded hippocampus volumes which resulted in reduced spill in of the choroid plexus into the hippocampus. Approximately 40% ± 10% of the total hippocampal voxels were removed for the most optimal eroded hippocampus VOI ([@bib0013]). For this reason, in the present study, three hippocampal volumes of interest(VOIs) were generated: a non- optimized 100% hippocampal VOI\[100%\] (Hammers atlas-based), and automatically eroding a percentage of the highest hippocampus BP~ND~ voxels (i.e. lowering spill-in) resulting in optimized 50% \[50%HDH\] and 40% \[40%HDH\] hippocampal VOIs. In a subset of our study population (*n* = 10 controls), the choroid plexus was manually drawn on the RPM BP~ND~ image to calculate to choroid plexus / hippocampus ratio for the time window 100 to 130 min post injection. We visually assessed all PET scans and confirmed that the removed voxels showed possible overlap between the choroid plexus and hippocampus (see [Fig. 1](#fig0001){ref-type="fig"}). In addition, only the eroded VOIs were partial volume corrected with HDH. This PVC method is a combination of Van Cittert iterative deconvolution (VC IDM) and HYPR denoising (HDH) ([@bib0016]).Fig. 1RPM BP~ND~ PET images with examples of the different hippocampal VOIs (100% original, HDH 50%, HDH 40%) for a cognitively normal participant(A) and MCI/AD patient (B). For the cognitively normal participant the hippocampal VOI is depicted in white and high choroid plexus binding in red (as depicted by the orange arrow). For the MCI/ AD patients the hippocampal VOI is depicted in red and high choroid plexus binding in green (as depicted by the orang arrow). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 1

2.3. Neuropsychological examination {#sec0005}
-----------------------------------

The Mini-Mental State Examination (MMSE) was used as a measure for global cognition ([@bib0032]). The Dutch translation of the Rey Auditory verbal learning (RAVLT, delayed recall condition) was used as a memory specific task, previously shown to be strongly associated with hippocampal function ([@bib0033]; [@bib0034]).

In addition, to further characterize our MCI/ AD group, we assessed four cognitive domains ([@bib0035]), including memory (Dutch version of the Rey Auditory Verbal Learning Test immediate recall and delayed recall, Visual Association Test (VAT) version A), attention (Digit span Forward, Trial Making Test (TMT) version A, Stroop word and color naming), executive functioning (Digit span Backward, TMT version B, letter fluency test (D-A-T) and Stroop color naming) and language (VAT naming and category fluency version animals). Z-scores for the Trail Making Tests and Stroop tests were inverted so that lower scores indicated worse performance. For cognitive domain scores, we created composite scores by averaging Z scores for each individual test within a domain (with a minimum of two tests per domain).

2.4. Statistical analysis {#sec0006}
-------------------------

Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS, IBM version 22) and R version 3.2.2 for area under the curve (AUC) comparisons and bootstrap sensitivity analysis). Independent samples T-tests were used to calculate group differences for continuous variables between the controls and MCI/ AD patients ([table 1](#tbl0001){ref-type="table"}). We performed receiver operating characteristic (ROC) area-under-the-curve (AUC) analyses to investigate which hippocampal \[^18^F\]flortaucipir BP~ND~ VOI could best discriminate MCI/AD from CN. Differences in AUCs were assessed using bootstrap (*n* = 1000) procedures). We performed linear regressions to investigate associations between the hippocampal \[^18^F\]flortaucipir BP~ND~ VOIs and delayed recall on the RAVLT or MMSE, while adjusting for age, sex and education. 95% confidence intervals were computed to test whether the relationships between \[^18^F\]flortaucipir BP~ND~ and cognition overlapped or differed across VOIs.Table 1Clinical and demographic data.Table 1Total group (*n* = 109)CN (*n* = 45)MCI/AD(*n* = 64)Age66±766±866±7Sex (% female)53 (49%)21(47%)32(50%)Amyloid status (%positive)80(73%)16(36%)64(100%)^⁎⁎^Education (Verhage score; range 1--7)5.5 ± 1.25.6 ± 1.25.4 ± 1.1MMSE (max 30)25±529±123±4^⁎⁎^RAVLT Delayed recall (max 15)5.5 ± 4.59.5 ± 3.22.6 ± 2.8\*\*Memory domain−2.0 ± 2.5 (*n* = 108)0.1 ± 0.8(*n* = 44)−3.4 ± 2.2 (*n* = 64)\*\*Executive domain−0.5 ± 1.2 (*n* = 96)0.3 ± 0.8 (*n* = 44)−1.1 ± 0.1(*n* = 52)\*\*Attention domain−0.6 ± 1.3 (*n* = 99)0.2 ± 0.7(*n* = 45)−1.3 ± 1.2 (*n* = 54)\*\*Language domain−0.5 ± 1.3 (*n* = 96)0.1 ± 0.7(*n* = 43)−0.9 ± 0.9 (*n* = 53)\*\*BP~ND~ orig 100%0.19±0.170.07±0.130.27±0.15\*\*BP~ND~ HDH 50%0.03±0.14−0.07±0.120.09±0.12\*\*BP~ND~ HDH 40%−0.01±0.13−0.09±0.110.05±0.11\*\*[^1][^2][^3]

Based on our a priori assumptions that optimizing the hippocampal VOI would result in more pronounced effects in subjects with higher hippocampal tau load or off-target \[^18^F\]flortaucipir choroid plexus uptake, we performed two additional analyses. First, since higher age is associated with higher \[^18^F\]flortaucipir choroid plexus binding ([@bib0005]; [@bib0006]), we evaluated the effect of age by performing linear regressions between \[^18^F\]flortaucipir BP~ND~ VOIs and delayed recall stratified for age (≤ 66.1 and \>66.1 years, based on a median spit of the sample). This analysis was performed across the whole group and adjusted for sex and education. Second, we aimed to assess the effect of global cortical tau BP~ND~ within each diagnostic group. We therefore divided global cortical tau load in tertiles (low, medium and high) per diagnosis (CN vs. MCI/AD). These analyses were adjusted for age, sex and education.

3. Results {#sec0007}
==========

3.1. Participants {#sec0008}
-----------------

Demographics and clinical data are presented in [Table 1](#tbl0001){ref-type="table"}. On average, participants were 66 ± 7 years, 49% female and had a MMSE score of 25 ± 5.There were no significant differences in age, education and sex between the different diagnostic groups (all *p* \> 0.05). MMSE and delayed recall scores were lower for the MCI/ AD patients than cognitively normal subjects and we found higher hippocampal BP~ND100%~ in MCI/AD (BP~ND100%~= 0.27±0.15) compared to cognitively normal subjects (BP~ND100%~= 0.07±0.13).

3.2. MCI/ AD vs. cognitively normal subjects {#sec0009}
--------------------------------------------

All methods showed comparable discriminative effects between MCI/AD dementia and cognitively normal subjects (AUC~100%~=0.85\[CI=0.78--0.93\]; AUC~50%HDH~=0.84 \[CI=0.74--0.92\]; AUC~40%HDH~=0.83 \[CI=0.74--0.92\], [Fig. 2](#fig0002){ref-type="fig"}). Bootstrapping revealed no differences in AUCs between methods (all *p* \> 0.05).Fig. 2Receiver operating characteristic curves of different hippocampal volume of interest (VOI) methods for distinguishing MCI/AD from CN. BP~ND~ = binding potential, HDH = Van Cittert iterative deconvolution and HYPR denoising.Fig. 2

3.3. Associations between \[^18^F\]flortaucipir hippocampal VOIs and cognition {#sec0010}
------------------------------------------------------------------------------

Associations between the different hippocampal VOIs and cognition are presented in [Fig. 3](#fig0003){ref-type="fig"}. Across groups, higher hippocampal \[^18^F\]flortaucipir BP~ND~ was related to lower scores on MMSE (standardized betas; β~100%~=−0.38\[CI=−0.57−0.20\]; β~50%HDH~= −0.37\[CI=−0.54 −0.19\]; β~40%HDH~=−0.35\[CI=−0.53 −0.17\]), delayed recall (standardized β~100%~=−0.64\[CI=−0.79 −0.49\]; β~50%HDH~= −0.61\[CI=−0.76 −0.46\]; β~40%HDH~=−0.59\[CI=−0.75 −0.44\]; all *p* \< 0.001)). The 95% confidence intervals overlapped across methods and thus effect sizes were considered comparable across all hippocampal VOIs ([Fig. 2](#fig0002){ref-type="fig"}). Within diagnostic groups, similar results were observed across the three hippocampal VOIs ([Fig. 2](#fig0002){ref-type="fig"}).Fig. 3Distribution of standardized Beta ± 95% confidence intervals for the association the different hippocampal VOIs between MMSE (A) and delayed recall (B) for the total group and per diagnosis.Fig. 3

We furthermore investigated associations between the BP~ND~ in the different hippocampal VOI definitions and delayed recall across two age groups divided by median split. Associations were essentially comparable between the different methods and for the different age groups (≤ 66.1 years, β~100%~=−0.72\[CI=−0.92 −0.52\], β~50%~=−0.73\[CI=−0.94 −0.53\], β~40%~=−0.71\[CI=−0.92 −0.50\] vs. \>66.1 years β~100%~=−0.59\[CI=−0.82 −0.36\] β~50%~= −0.57\[CI=−0.81−0.34\], β~40%~=−0.57\[CI=−0.81−0.33\]). When we further investigated associations between the different hippocampal tau VOIs and memory function for the different global cortical tau load groups, all methods showed comparable performance (see [Table 2](#tbl0002){ref-type="table"}).Table 2associations between the different hippocampal VOIs and delayed recall per Tau load stratified for diagnosis.Table 2[Hippocampal VOI]{.ul}Cognitively normal participants (*n* = 45)MCI / AD (*n* = 64)β(95% CI)β(95% CI)Low tau load (*n* = 15)Medium tau load (*n* = 15)High tau load (*n* = 15)Low tau load (*n* = 21)Medium tau load (*n* = 22)High tau load (*n* = 21)[100%]{.ul}0.39 (−0.4--1.2)−0.27 (−1.0--0.4)−0.38 (−1.1--0.4)−0.49 (−1.0--0.1)−0.31 (−0.8--0.2)−0.47 (−0.8--0.0)[HDH 50%]{.ul}0.47 (−0.2--1.1)−0.02 (−0.8--0.8)−0.44 (−1.1--0.3)−0.47 (−0.9--0.2)−0.21 (−0.7--0.3)−0.57 (−1.0--0.2)[HDH 40%]{.ul}0.38 (−0.2--1.0)−0.01 (−0.8--0.87)−0.42 (−1.1--0.3)−0.36 (−0.9--0.2)−0.21 (−0.7--0.27)−0.58 (−1.0--0.2)[^4]

4. Discussion {#sec0011}
=============

In this study, we compared several methods to diminish spill-in effects of hippocampal \[^18^F\]flortaucipir binding. A non optimized 100% hippocampal VOI (BP~ND100%~) and two additional optimized hippocampal VOIs were generated by combining Van Cittert iterative deconvolution and HYPR denoising (HDH) partial volume correction with eroding a percentage of the highest hippocampus BP~ND~ voxels (50% HDH and 40% HDH). We examined which method was able to distinguish AD from cognitively normal individuals and investigated its associations with measures of cognition. We concluded that the performance was comparable for all methods, and that after optimization the hippocampal VOIs retained strong clinico-pathological relationships.

In recent work ([@bib0013]), we showed that the combination of partial volume correction (i.e. HDH) and eroding the hippocampus attenuated the relationship between hippocampal \[^18^F\]flortaucipir and choroid plexus binding, indicating less spill-in from choroid plexus to neighboring hippocampus. Integrating our previous findings with the outcomes of the present study, we now show that optimization of the hippocampal tau signal leads to less spill in of the choroid plexus without the introduction of noise, since the relationship with clinical AD diagnosis and cognitive performance were comparable before and after correction.

Although the results of our previous study ([@bib0013]) suggests that eroding and PVC resulted in a more accurate quantification of tau load, the isolated results of the present study show comparable results for non-optimized and optimized hippocampal VOIs. Thus non-optimized hippocampal VOIs are probably sufficient for clinical interpretation*,* for instance for discriminative accuracy of \[^18^F\]flortaucipir between controls and MCI/AD groups or for correlational analysis of \[^18^F\]flortaucipir binding with global cognitive measures such as MMSE. As such, we do not recommend use of PVC and VOI erosion for these purposes, but readers should be aware that accurate assessment of hippocampal uptake will require a proper correction for CP spillover and may be required in case of smaller effect sizes between subject groups or for longitudinal studies

In line with previous literature\[6, 15\], we showed that the uncorrected hippocampal VOI discriminated between AD patients and cognitively normal subjects and optimizing hippocampal tau uptake did not significantly diminish the discriminative ability. [@bib0006]) showed that PVC resulted in a large increase of signal in the choroid plexus, which suggests that the spill-out of signal of the choroid plexus is decreased. Although there was an minimal change in the amount of hippocampal \[^18^F\]flortaucipir tracer uptake, the PVC may ameliorate the estimation of the hippocampal \[^18^F\]flortaucipir. Similar to the present study, uncorrected data also showed a clear distinction between AD patients and cognitively normal subjects and PVC data was preferred because it marginally outperformed PVC uncorrected data without altering its associations with diagnosis. In addition, [@bib0012]) studied two different approaches to correct for the confounding effect of the choroid plexus and concluded that after correction hippocampal tau retained its association with clinical diagnosis. While using PVC and linear regressions methods, they found a significant relationship between hippocampal and choroid plexus tau load (*r* = 0.39) and a significant decrease after both corrections (*r* = 0.14--0.19). In line with results of the current study and recent work ([@bib0013]), \[^18^F\]flortaucipir uptake in the hippocampus was improved after correction, while the discriminative ability of the hippocampus remained excellent and comparable with uncorrected hippocampus tau signal.

In a second approach we investigated the associations between hippocampal tau and cognitive functioning, and we found that optimization of hippocampal \[^18^F\]flortaucipir binding did not alter the strong associations between tau PET and cognition. Relationships between hippocampal tau and cognition were comparable for all methods, which enhances the conclusion that the non-optimized hippocampal VOI is sufficient for clinical interpretation. This is in line with other tau PET studies, in which associations between PVC \[^18^F\]flortaucipir and cognition were equivalent to the uncorrected data ([@bib0004]; [@bib0006]; [@bib0036]). However, Lee et al.\[11\] examined the relationship between hippocampal tau load and cognition specifically, and showed that the adjustment of \[^18^F\]flortaucipir standardized uptake value ratio (SUVr) in the hippocampus by means of partial residuals and PVC resulted in a stronger relationship with cognition. They used a combination of PVC and partial residuals of the hippocampus to correct for the choroid plexus spill in and extracted the hippocampus residuals from the univariate regression between the choroid plexus and hippocampus. With the aforementioned method they showed that the adjusted hippocampal SUVr was associated with memory scores in amyloid positive participants, while unadjusted hippocampal uptake was not. A possible explanation for this discrepancy in results is that [@bib0011]) used SUVr. SUVr is susceptible to differences in tracer delivery between patients, i.e. dependent of the velocity of wash in and wash out of the tracer ([@bib0037]). Especially in AD patients ([@bib0038]), where flow effects are expected, SUVr is less reliable than BP~ND~ which was used in our study. In addition, Lee et al. used of a different PVC method, the geometric transfer matrix(GTM) ([@bib0039]). GTM requires an MR image of the brain, while in our study we specifically obtained for a method in that could use a "PET only" PVC method which is less susceptible for VOI definition, registration and segmentation errors and may therefore be more accurate than MR based methods. Moreover, the study was conducted in a normal aging population, with a higher mean age (75.9 compared to 66.9 years in our cohort). As choroid plexus binding increases with age ([@bib0005]; [@bib0006]), adjustment of the hippocampus VOI may affect results more in the case of higher choroid plexus signal, e.g. in older age.

There are several limitations. First, we automatically eroded the hippocampus based on the voxel BP~ND~ values. The rationale for choosing this method is that the choroid plexus had much higher uptake, resulting in higher BP~ND,~ than the hippocampus. To assess the extent of difference, the ratio of the uptake between the choroid plexus and hippocampus (using 100--130 min scan duration) for a subset of our study population (*n* = 10 controls) was calculated. The choroid plexus uptake was 1.6 times higher (1.1--2.7) relative to the hippocampus for visually high uptake cases. For visually low uptake cases, the choroid plexus uptake was 1.3 times higher (range 1.1--1.6) than the hippocampus. This demonstrates that the spill-in of the choroid plexus may have a high impact on the BP~ND~ of the hippocampus. The highest intensity voxels in the hippocampus would be inherently the voxels that suffer from spill-in from the choroid plexus. This is also depicted in [Fig. 1](#fig0001){ref-type="fig"}, where the voxels at the hippocampus-choroid plexus border that suffer from spill-in are deleted. Since the choroid plexus has a wide anatomical variety and does not show a uniform high uptake pattern throughout the plexus, a voxel based method is presumably more accurate than a region-of-interest based method.

Second, we used cerebellar grey matter as a reference region. Our previous kinetic modelling work showed that there was no difference in the volume of distribution (V~T~) values of the whole grey matter cerebellum, indicating that this is a reliable reference region for our study population ([@bib0026]). Another recent study of ours presented a high test-retest repeatability of \[^18^F\]flortaucipir kinetics when using cerebellar gray matter as a reference region and dynamic scans, suggesting grey matter cerebellum is a reliable reference region ([@bib0031]).

Third, we did not have neuropathological confirmation of the off-target binding in the choroid plexus. As suggested by others, several substrates of this off-target binding are proposed including calcification/ mineralization ([@bib0010]) and leptomeningeal melanocytes ([@bib0003], [@bib0040]). The latter is confirmed by an in vivo study in which Black/African Americans showed higher flortaucipir choroid plexus binding compared to White participants, but not in other regions ([@bib0011]). However, some argue that part of the signal in the choroid plexus may be actually on-target, that is binding to a structure called "Biondi ring" (tau) tangles ([@bib0041]). This has yet to be confirmed by other post mortem studies. Fourth, the average age of our sample was relatively low. Since choroid plexus binding increases with age ([@bib0005]; [@bib0006]), this may have underestimated the value of partial volume correction.

In summary, among patients of a memory clinic we earlier described a reduction of the association between hippocampal and choroid plexus \[^18^F\]flortaucipir retention after the combination of HDH PVC and eroding ([@bib0013]). After applying and adjusting this method for clinical purposes, we showed that automated HDH 50% and 40% hippocampal \[^18^F\]flortaucipir BP~ND~ retains comparable strong relationships with cognition. Although there is still a need for accurate quantitative assessment of the hippocampal \[^18^F\]flortaucipir uptake, the non-optimized hippocampal VOI may be accurate enough for clinical interpretation, since both discrimination between diagnostic groups and associations between hippocampal \[^18^F\]flortaucipir BP~ND~ and memory were comparable for all methods.
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[^1]: Data is presented as mean ± SD or number (%). Education scoring is according to the Verhage (1965) system. Neuropsychological test scores were standardized into Z-scores prior to transformation into domain scores. MMSE, Mini-Mental State Examination RAVLT = Dutch version of the Rey Auditory Verbal Learning Test. AD significantly different from CN at.

[^2]: \*\**p*\<0.01.

[^3]: \**p*\<0.05.

[^4]: Data is presented as standardized Beta± 95% confidence intervals(CI) between brackets\*\**p*\<0.01, \**p*\<0.05. Analyses were adjusted for age, gender and education. Associations were calculated between hippocampal VOI and delayed recall, per diagnostic group (cognitively normal participants vs. MCI/AD) and per tau load (tertiles). Tau load was based on global BP~ND~ (VOI = volume of interest, HDH = Van Cittert iterative deconvolution and HYPR denoising).
